Loading…
Nuwellis, Inc. is projected to rise to $4.00 by 2027, a +39% move from its current price of $2.88. NUWE is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 12 | $2.67 | $2.89 | $3.11 | +0.18% |
| Jul 13 | $2.59 | $2.89 | $3.22 | +0.36% |
| Jul 14 | $2.54 | $2.90 | $3.30 | +0.54% |
| Jul 15 | $2.49 | $2.90 | $3.38 | +0.72% |
| Jul 16 | $2.45 | $2.91 | $3.45 | +0.90% |
| Jul 17 | $2.42 | $2.91 | $3.51 | +1.08% |
| Jul 18 | $2.38 | $2.92 | $3.57 | +1.27% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $2.38 | $2.92 | $3.57 | +1.27% |
| Week 2 | $2.22 | $2.95 | $3.93 | +2.55% |
| Week 3 | $2.11 | $2.99 | $4.24 | +3.85% |
| Week 4 | $2.02 | $3.03 | $4.53 | +5.16% |
| Week 5 | $1.95 | $3.07 | $4.81 | +6.49% |
| Week 6 | $1.90 | $3.11 | $5.09 | +7.84% |
| Week 7 | $1.84 | $3.15 | $5.36 | +9.20% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Nuwellis, Inc. is a healthcare company that develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The Aquadex FlexFlow and Aquadex SmartFlow systems are used to treat patients suffering from fluid overload due to heart failure.
The Aquadex SmartFlow system for temporary use is available in adult and pediatric patients. Nuwellis, Inc. was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc.
in April 2021. The company was founded in 1999 and is headquartered in Eden Prairie, Minnesota.
Nuwellis, Inc. trades under the symbol NUWE and its current price is $2.87. Its market capitalization is $264.62K, and the stock is ranked 5510.
A major floor 96.9% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.3% away) — a key level to hold.
The nearest ceiling, 933.0% above — a clean break opens room to run.
A major ceiling 933.0% above — clearing it would confirm fresh momentum.
Key NUWE support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of NUWE market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $3.05 | Sell | $2.97 | Sell |
| MA 10 | $3.11 | Sell | $2.67 | Buy |
| MA 20 | $1.62 | Buy | $2.06 | Buy |
| MA 50 | $1.15 | Buy | $1.47 | Buy |
| MA 100 | $1.21 | Buy | $1.71 | Buy |
| MA 200 | $1.96 | Buy | $25.92 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 74.70 | Sell |
| Stoch RSI (14) | 80.35 | Sell |
| CCI (20) | 63.76 | Neutral |
| Williams %R (14) | -8.10 | Info |
| MACD (12,26,9) | 0.15 | Buy |
| ROC (12) | 2238.46 | Buy |
| Bollinger %B (20,2) | 0.74 | Neutral |
| Stochastic %K (14) | 91.90 | Sell |
| TRIX (15) | 8.56 | Buy |
| Awesome (5,34) | 1.86 | Buy |
| Ultimate (7,14,28) | 62.52 | Neutral |
| Momentum (10) | 2.95 | Buy |
| Aroon Osc (25) | 4.00 | Buy |
| Hull MA (9) | 2.92 | Sell |
| ADX (14) | 60.85 | Buy |
| ATR (14) | 0.19 | Info |
The 30-day technical picture is Neutral in sentiment. RSI (14) is 10, indicating limited momentum. The stock trades with a 50-day simple moving average of $20.52 and a 200-day simple moving average of $64.67.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $2.87 | $2.88 | $4.82 | 0% | Neutral | |
| $2.91 | $4.00 | $5.97 | +39% | Bullish | |
| $3.00 | $4.40 | $6.98 | +53% | Bullish | |
| $2.95 | $4.56 | $7.59 | +58% | Bullish | |
| $2.06 | $3.34 | $5.79 | +16% | Neutral | |
| $1.98 | $3.34 | $6.01 | +16% | Neutral | |
| $2.30 | $4.06 | $7.52 | +41% | Bullish | |
| $2.63 | $4.82 | $9.18 | +67% | Bullish | |
| $3.06 | $5.85 | $11.42 | +103% | Bullish | |
| $2.59 | $5.14 | $10.27 | +79% | Bullish | |
| $3.53 | $7.85 | $17.23 | +173% | Bullish | |
| $4.02 | $8.93 | $20.55 | +210% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $2.87 | $2.88 | $3.88 | +0.00% |
| August 2026 | $2.87 | $3.47 | $4.38 | +20.57% |
| September 2026 | $2.76 | $3.39 | $4.37 | -2.29% |
| October 2026 | $2.76 | $3.43 | $4.50 | +1.07% |
| November 2026 | $2.92 | $3.67 | $4.88 | +6.95% |
| December 2026 | $2.82 | $3.58 | $4.82 | -2.50% |
Click any year to see its month-by-month NUWE forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, NUWE is projected to trade between $2.87 and $4.82, averaging $2.88 — a potential gain of 0% from today's $2.88. Price action looks broadly range-bound.
Nuwellis, Inc.'s 2027 outlook centres on $4.00, within a $2.91 to $5.97 range. That is up +39% on the projected 2026 average. That marks a +39% change versus current levels. Buyers look set to stay in control over this stretch.
By 2028, NUWE could reach as high as $6.98, with a base case around $4.40 and support toward $3.00 — roughly +53% from $2.88. Momentum favours further upside here.
Expect NUWE to range from $2.95 to $7.59 through 2029. The $4.56 average target implies a +58% move from current prices. That is up +4% on the projected 2028 average. Buyers look set to stay in control over this stretch.
The NUWE price prediction for 2030 points to an average of $3.34 (low $2.06, high $5.79) — a potential gain of +16% on today's $2.88. Price action looks broadly range-bound.
In 2031, NUWE is projected to trade between $1.98 and $6.01, averaging $3.34 — a potential gain of +16% from today's $2.88. That is up 0% on the projected 2030 average. A consolidation phase looks the most probable path here.
Nuwellis, Inc.'s 2032 outlook centres on $4.06, within a $2.30 to $7.52 range. That is up +21% on the projected 2031 average. That marks a +41% change versus current levels. Momentum favours further upside here.
By 2033, NUWE could reach as high as $9.18, with a base case around $4.82 and support toward $2.63 — roughly +67% from $2.88. Buyers look set to stay in control over this stretch.
Expect NUWE to range from $3.06 to $11.42 through 2034. The $5.85 average target implies a +103% move from current prices. That is up +21% on the projected 2033 average. Momentum favours further upside here.
The NUWE price prediction for 2035 points to an average of $5.14 (low $2.59, high $10.27) — a potential gain of +79% on today's $2.88. Buyers look set to stay in control over this stretch.
In 2040, NUWE is projected to trade between $3.53 and $17.23, averaging $7.85 — a potential gain of +173% from today's $2.88. That is up +53% on the projected 2035 average. Momentum favours further upside here.
Nuwellis, Inc.'s 2050 outlook centres on $8.93, within a $4.02 to $20.55 range. That is up +14% on the projected 2040 average. That marks a +210% change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in NUWE today (≈ 347.222222 NUWE) could be worth
$3,101.61
+$2,101.61 (+210%) by 2050 · US Dollar
Based on the average projected NUWE price of $8.93 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in NUWEwould be worth at today's price.
$1,000 invested in NUWE on Jul 10, 2025 (≈ 134.228191 NUWE) would be worth
$386.58
-$613.42 (-61.3%) today · 0.39× · US Dollar
Based on a NUWE entry price of $7.45 vs. today's $2.88.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $3.15 | $914.29 | -8.6% |
| 1 month ago | $0.15 | $19,200 | +1820.0% |
| 3 months ago | $1.09 | $2,642.2 | +164.2% |
| 6 months ago | $2.02 | $1,425.74 | +42.6% |
| 1 year ago | $7.45 | $386.58 | -61.3% |
| All time (5.0y) ago | $582,120 | $0 | -100.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our NUWE forecast.
Our base-case forecast reaches $5.80 around 2034.
Implied market cap at $5.80: $534.77K
The multi-year forecast shows a mixed but growing outlook. For 2026, the min, avg, and max prices are $2.87, $2.87, and $4.78 respectively with a 0% ROI and Neutral sentiment. The years 2027 through 2029 turn bullish, with 2027 avg $4.00, max $5.97 and ROI 39.4%; 2028 avg $4.40, max $6.98 and ROI 53.2%; 2029 avg $4.52, max $7.54 and ROI 57.5%.
In 2030 the min/avg/max are $2.05, $3.32, and $5.77 with ROI 15.8% and Neutral sentiment, followed by 2031 min $1.98, avg $3.34, max $6.00 and ROI 16.4%. The forecast turns bullish again in 2032 with avg $4.04, max $7.49 and ROI 40.9%; 2033 avg $4.81, max $9.17 and ROI 67.7%; 2034 avg $5.83, max $11.39 and ROI 103.3%; 2035 avg $5.11, max $10.20 and ROI 77.9%. The projection remains bullish into 2040 with avg $7.86, max $17.26 and ROI 173.8%, and by 2050 with avg $8.83, max $20.31 and ROI 207.6%.
Tap a question to reveal the answer.
2030 min $2.05, avg $3.32, max $5.77; ROI 15.8%; sentiment NEUTRAL.
The forecast shows neutral in 2026, bullish in 2027–2029 and 2032–2035, with ROIs ranging from 0% to 207.6% (e.g., 39.4% in 2027, 53.2% in 2028, 57.5% in 2029, 40.9% in 2032, 67.7% in 2033, 103.3% in 2034, 77.9% in 2035, 173.8% in 2040, and 207.6% in 2050).
Yes. The 2034 maximum in the forecast is $11.39.
Current price is $2.87 and market cap is $264.62K.
Sentiment: NEUTRAL. RSI (14): 10. SMA50: $20.52. SMA200: $64.67. 30-day range: $1.70 to $4.85. Support: $2.87. Resistance: $31.85.
Nuwellis, Inc. Community Discussion
0Share your Nuwellis, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.